ROYAL BANK OF CANADA - ZOSANO PHARMA CORP ownership

ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 36 filers reported holding ZOSANO PHARMA CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ZOSANO PHARMA CORP
ValueSharesWeighting
Q1 2022$01320.0%0.00%
Q4 2021$0132
-65.4%
0.00%
Q3 2021$0382
+189.4%
0.00%
Q2 2021$01320.0%0.00%
Q1 2021$0
-100.0%
132
-96.4%
0.00%
Q4 2020$2,000
-80.0%
3,632
-40.8%
0.00%
Q3 2020$10,0006,133
+1392.2%
0.00%
Q2 2020$0411
+1.7%
0.00%
Q1 2020$0
-100.0%
404
-94.9%
0.00%
Q4 2019$12,000
+1100.0%
7,900
+1655.6%
0.00%
Q3 2019$1,0004500.00%
Other shareholders
ZOSANO PHARMA CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,600,000$7,632,0005.81%
Telemetry Investments, L.L.C. 242,826$1,158,0000.59%
MYDA Advisors LLC 72,000$343,0000.17%
Highlander Capital Management, LLC 10,000$48,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$4,770,0000.01%
Hartford Financial Management Inc. 2,000$10,0000.00%
GABELLI FUNDS LLC 21,297$102,0000.00%
IFP Advisors, Inc 1,248$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 81,829$390,0000.00%
DEUTSCHE BANK AG\ 100$00.00%
View complete list of ZOSANO PHARMA CORP shareholders